메뉴 건너뛰기




Volumn 281, Issue 4 50-4, 2001, Pages

Bradykinin receptor antagonists attenuate neointimal proliferation postangioplasty

Author keywords

Angioplasty; HOE 140; Human; Porcine; Restenosis; Vascular smooth muscle

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; ICATIBANT; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

EID: 0034785944     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.281.4.h1648     Document Type: Article
Times cited : (13)

References (39)
  • 6
    • 0028170580 scopus 로고
    • q-α potentiates platelet-derived growth factor-stimulated mitogenesis in confluent cell cultures
    • (1994) J Biol Chem , vol.269 , pp. 19671-19674
    • De Vivo, M.1    Iyengar, R.2
  • 12
    • 0028836952 scopus 로고
    • Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril
    • The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group
    • (1995) J Am Coll Cardiol , vol.25 , pp. 362-369
    • Faxon, D.P.1
  • 20
    • 0029593586 scopus 로고
    • Role of basic fibroblast growth factor and platelet-derived growth factor (B-chain) in neointima formation after arterial injury
    • (1995) Z Kardiol , vol.84 , Issue.SUPPL. 4 , pp. 137-144
    • Lindner, V.1
  • 25
    • 0026766194 scopus 로고
    • Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial
    • Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group
    • (1992) Circulation , vol.86 , pp. 100-110


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.